Plandaí Biotechnology, Inc. (PLPL)

Market Cap	8.89K
Revenue (ttm)	338.48K
Net Income (ttm)	-4.32M
Shares Out	8.89B
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	990,000
Average Volume	2,123,893
Open	n/a
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0007
Beta	6.79
RSI	43.76
Earnings Date	n/a

About Plandaí Biotechnology

Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnolo...

• Industry: Shell Companies
• Sector: Financials
• CEO: Roger Baylis-Duffield
• Employees: 180
• Stock Exchange: OTCMKTS
• Ticker Symbol: PLPL

Financial Performance

In 2016, Plandaí Biotechnology's revenue was $298,494, an increase of 221.31% compared to the previous year's $92,898. Losses were -$4.38 million, -54.30% less than in 2015.